Zobrazeno 1 - 10
of 168
pro vyhledávání: '"Daeho Cho"'
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 16 (2022)
Activation of microglia, which is the primary immune cell of the central nervous system, plays an important role in neuroinflammation associated with several neuronal diseases. Aminoacyl tRNA synthetase (ARS) complex-interacting multifunctional prote
Externí odkaz:
https://doaj.org/article/62135d1c9bfe48ed98bf96cfc6d08ce8
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Threonyl-tRNA synthetase (TRS) is an aminoacyl-tRNA synthetase that catalyzes the aminoacylation of tRNA by transferring threonine. In addition to an essential role in translation, TRS was extracellularly detected in autoimmune diseases and also exhi
Externí odkaz:
https://doaj.org/article/621f794535b74d249b19238c76284118
Publikováno v:
Molecules, Vol 26, Iss 4, p 1168 (2021)
Peptide materials have recently been considered for use in various industrial fields. Because of their efficacy, safety, and low cost, therapeutic peptides are studied for various diseases, including atopic dermatitis (AD). AD is a common inflammator
Externí odkaz:
https://doaj.org/article/d228e16fbaa24a3084b3d0df6ec6a742
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
T helper type 17 (Th17) cells are a subset of pro-inflammatory T helper cells that mediate host defense and pathological inflammation. We have previously reported that host dendritic cells (DCs) infected with Vibrio vulnificus induce Th17 responses t
Externí odkaz:
https://doaj.org/article/e35d1fe9a6f140a89e73605bc09d1b88
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0179614 (2017)
Dysregulation of collagen production contributes to various pathological processes, including tissue fibrosis as well as impaired wound healing. Lipo-prostaglandin E1 (Lipo-PGE1), a lipid microsphere-incorporated prostaglandin E1, is used as a vasodi
Externí odkaz:
https://doaj.org/article/9da6f29cb3714e51b9c6d6e1e027c486
BackgroundActivation of microglia, which are the primary immune cell of the central nervous system, plays an important role in neuroinflammation associated with several neuronal diseases. Aminoacyl tRNA synthetase (ARS) complex-interacting multifunct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::288123d76a0fd8bab2f145222d4fc160
https://doi.org/10.21203/rs.3.rs-1475701/v2
https://doi.org/10.21203/rs.3.rs-1475701/v2
Publikováno v:
International Journal of Molecular Medicine
The erythroid differentiation regulator 1 (Erdr1) protein has been studied for its role in various inflammatory skin diseases, including skin cancer, actinic keratosis and psoriasis. However, the therapeutic effects of Erdr1 on wound repair and its u
Autor:
Myun Soo Kim, Dongmin Park, Sora Lee, Sunyoung Park, Kyung Eun Kim, Tae Sung Kim, Hyun Jeong Park, Daeho Cho
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 844, p 844 (2022)
International Journal of Molecular Sciences; Volume 23; Issue 2; Pages: 844
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 23; Issue 2; Pages: 844
International Journal of Molecular Sciences
Erythroid differentiation regulator 1 (Erdr1) has previously been reported to control thymocyte selection via TCR signal regulation, but the effect of Erdr1 as a TCR signaling modulator was not studied in peripheral T cells. In this report, it was de
Autor:
Tae Sung Kim, Daeho Cho, Su Jin Jung, Kyung Eun Kim, Myun Soo Kim, Sora Lee, Hyun Jeong Park, Sunyoung Park
Publikováno v:
Cellular Immunology. 336:28-33
Erythroid differentiation regulator 1 (Erdr1) has been identified as a stromal survival factor released under stressful conditions. Previously, Erdr1 was reported to be expressed highly in thymus, but roles of Erdr1 in thymus were not known. Here, th
Autor:
Jeongmin Park, Dong Yeon Kim, Daeho Cho, Dae Jin Cho, Kyung Eun Kim, Hyun Jeong Park, Sunyoung Park, Dae Young Hur, Soyoung Cheon
Publikováno v:
Journal of Immunology Research
Radotinib (Supect™) was developed to treat chronic myeloid leukemia (CML) as a BCR-ABL1 tyrosine kinase inhibitor (TKI). Other TKIs, including imatinib and nilotinib, were also developed for treatment of CML, and recent studies were increasing abou